Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standex International Corporation (NYSE: SXI) SEC filings page provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Standex’s financial performance, governance practices, executive compensation, and shareholder matters.
Standex submits a variety of forms, including Form 8-K current reports and its DEF 14A definitive proxy statement. Recent Form 8-K filings have covered topics such as the announcement of quarterly earnings, the results of the Annual Meeting of Shareholders, and changes in executive roles. Through these reports, investors can review information on segment performance across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, as well as commentary on revenue, margins, and capital allocation.
The company’s definitive proxy statement describes board leadership structure, board committees, strategy and risk oversight, ESG strategy and risks, director compensation, director independence, and stock ownership. It also details the items presented to shareholders for voting, including director elections, advisory votes on executive compensation, and ratification of the independent auditors.
On this page, filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy documents, helping users quickly identify topics such as shareholder vote outcomes, executive compensation disclosures, and significant corporate events reported on Form 8-K. Investors can use these summaries alongside the full-text filings to better understand Standex’s regulatory reporting and governance framework.
Standex International (SXI) reported insider purchases by Max Arets, Vice President and Chief Information Officer, under the company’s Dividend Reinvestment Plan on 08/21/2025. The Form 4 shows two small acquisitions of Common Stock: 1.178 and 0.1 shares at prices of $201.6214 and $202 respectively, increasing beneficial ownership to 1,318.532 and then 1,318.632 shares (direct ownership). The filing was signed by Alan J. Glass on 08/25/2025. The filing indicates routine reinvestment of dividends rather than open-market purchases or dispositions.
Standex International Corporation (SXI) director Robin J. Davenport reported a small acquisition of common stock on 08/21/2025 under the company’s Dividend Reinvestment Plan (DRIP). The Form 4 shows an acquisition code J(1) for 1.782 shares at a reported price of $201.538 per share, resulting in 4,059.089 shares beneficially owned following the transaction.
The filing indicates the form was filed by one reporting person and lists Davenport’s relationship to the issuer as a director. The signature block shows the form was signed by Alan J. Glass on 08/25/2025. The filer states the purchase was made pursuant to the company’s DRIP; no other transactions or derivative positions are reported.
Standex International Corp. (SXI) director Thomas J. Hansen reported a sale of common stock on 08/18/2025. The filing shows 2,992 shares sold in one or more transactions at a weighted average price of $202.6049, with individual sale prices ranging from $201.045 to $203.540. After the reported sale, the filing lists 8,439.254 shares beneficially owned by the reporting person in a direct ownership form. The Form 4 is executed on behalf of the reporting person by Alan J. Glass and signed on 08/20/2025. The filer is identified as a director of the issuer, Standex International Corporation (SXI).
Form 144 notice for Standex International Corporation (SXI) reports a proposed sale of 2,992 common shares through Fidelity Brokerage Services with an aggregate market value of $606,101.92. The filing lists 12,068,262 common shares outstanding and indicates the approximate date of sale as 08/18/2025 on the NYSE. The shares to be sold were acquired through restricted stock vesting: 1,171 shares on 09/06/2022, 1,035 shares on 10/25/2021 and 786 shares on 09/06/2021, each received as compensation. The filer reports no securities sold in the past three months and includes the standard representation about absence of undisclosed material information.
David A. Dunbar, President/CEO/Chairman and director of Standex International (SXI), reported a sale of company stock under a pre-existing 10b5-1 trading plan. On 08/13/2025 he disposed of 16,000 shares at $200 per share. The Form 4 also corrects prior reporting: 50,962 shares were gifted to a trust for the benefit of the reporting person’s spouse on 09/12/2023 and the trust’s holdings were inadvertently omitted from subsequent reports. Following the reported sale, the filing shows the reporting person (as trustee) beneficially owned 115,576 shares (indirect). The sale was executed pursuant to trading plans dated November 22, 2024, and the Form 4 was signed on 08/14/2025.
Standex International director Charles H. Cannon Jr. filed an amended Form 4 clarifying insider trading reported for May 9, 2025. The amendment corrects an earlier filing that mistakenly showed a direct sale of 2,779 common shares; the amendment states that the sale was executed by a trust rather than by Mr. Cannon personally. The transaction price shown on the form is $154.67.
The filing indicates beneficial ownership following the reported transaction includes 13,751 shares held indirectly as Trustee of a trust and a separate direct position of 2,936 shares. The amendment was submitted to remedy the original Form 4 filed May 13, 2025, and the document is signed on August 14, 2025.
Wasatch Advisors LP reports beneficial ownership of 866,830 shares of Standex International (SXI), representing 7.2% of the outstanding common stock. Wasatch discloses sole dispositive power over all 866,830 shares and sole voting power over 625,398 shares, with no shared voting or dispositive power reported.
The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control. The report classifies Wasatch as an investment adviser, making this a public notice that a registered adviser holds a material, passive stake in the company.
Standex International Corporation's Form 144 notifies a proposed sale of 16,000 shares of common stock on the NYSE through UBS Financial Services with an approximate aggregate market value of $3,200,000, and an indicated sale date of 08/13/2025. The filing lists 12,068,262 shares outstanding, which places the proposed sale at roughly 0.13% of the outstanding common stock.
The securities were acquired by the selling person through vested restricted stock units: 4,206 shares on 08/23/2023, 6,794 shares on 09/06/2023, and 5,000 shares on 09/06/2022. The form reports Nothing to Report for sales in the past three months. Several identifying fields in the filing (for example, filer CIK and issuer name/address sections) are blank or not populated in the provided text.
Champlain Investment Partners, LLC reported beneficial ownership of 603,095 shares of Standex International common stock, equal to 5.0% of the class. The filing shows Champlain has sole dispositive power over all 603,095 shares and sole voting power over 388,520 shares, with no shared voting or dispositive authority. The filer identifies itself as an investment adviser.
The filing includes a certification that the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control. The statement is signed by the firm's Chief Compliance Officer.
Standex International Corp. director Robin J. Davenport reported two small acquisitions of Common Stock under the company's Dividend Reinvestment Plan during the fiscal year. The filings show purchases of 1.918 shares on 02/27/2025 and 2.389 shares on 05/22/2025, recorded as acquisitions rather than open-market trades.
After these reinvestments the reporting person's direct beneficial ownership is listed as 4,057.307 shares at the end of the issuer's fiscal year. The form explicitly states these additions were made pursuant to the company's Dividend Reinvestment Plan, and the holdings are reported as direct ownership.